Nano-ghosts

Novel biomimetic nano-vesicles for the delivery of antisense oligonucleotides

Journal Article (2021)
Author(s)

Jacopo Oieni (Technion Israel Institute of Technology)

Andrea Lolli (Erasmus MC)

Domenico D'Atri (Technion Israel Institute of Technology)

N. Kops (Erasmus MC)

Avner Yayon (Procore Ltd, Ness Ziona)

G.J.V.M. van Osch (Erasmus MC, TU Delft - Biomaterials & Tissue Biomechanics)

Marcelle Machluf (Technion Israel Institute of Technology)

Research Group
Biomaterials & Tissue Biomechanics
Copyright
© 2021 Jacopo Oieni, Andrea Lolli, Domenico D'Atri, Nicole Kops, Avner Yayon, G.J.V.M. van Osch, Marcelle Machluf
DOI related publication
https://doi.org/10.1016/j.jconrel.2021.03.018
More Info
expand_more
Publication Year
2021
Language
English
Copyright
© 2021 Jacopo Oieni, Andrea Lolli, Domenico D'Atri, Nicole Kops, Avner Yayon, G.J.V.M. van Osch, Marcelle Machluf
Research Group
Biomaterials & Tissue Biomechanics
Bibliographical Note
Green Open Access added to TU Delft Institutional Repository 'You share, we take care!' - Taverne project https://www.openaccess.nl/en/you-share-we-take-care Otherwise as indicated in the copyright section: the publisher is the copyright holder of this work and the author uses the Dutch legislation to make this work public.@en
Volume number
333
Pages (from-to)
28-40
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

Antisense oligonucleotides (ASOs) carry an enormous therapeutic potential in different research areas, however, the lack of appropriate carriers for their delivery to the target tissues is hampering their clinical translation. The present study investigates the application of novel biomimetic nano-vesicles, Nano-Ghosts (NGs), for the delivery of ASOs to human mesenchymal stem cells (MSCs), using a microRNA inhibitor (antimiR) against miR-221 as proof-of-concept. The integration of this approach with a hyaluronic acid-fibrin (HA-FB) hydrogel scaffold is also studied, thus expanding the potential of NGs applications in regenerative medicine. The study shows robust antimiR encapsulation in the NGs using electroporation and the NGs ability to be internalized in MSCs and to deliver their cargo while avoiding endo-lysosomal degradation. This leads to rapid and strong knock-down of miR-221 in hMSCs in vitro, both in 2D and 3D hydrogel culture conditions (>90% and > 80% silencing efficiency, respectively). Finally, in vivo studies performed with an osteochondral defect model demonstrate the NGs ability to effectively deliver antimiR to endogenous cells. Altogether, these results prove that the NGs can operate as stand-alone system or as integrated platform in combination with scaffolds for the delivery of ASOs for a wide range of applications in drug delivery and regenerative medicine.

Files

1_s2.0_S0168365921001292_main.... (pdf)
(pdf | 4.48 Mb)
- Embargo expired in 16-09-2021
License info not available